Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.

Pharmacoepidemiology and Drug Safety
Eric S JohnsonDavid H Smith

Abstract

Angiotensin-converting enzyme (ACE) inhibitors are recommended for patients with chronic kidney disease (CKD) because they slow disease progression. But physicians' concerns about the risk of hyperkalemia (elevated serum potassium level), a potentially fatal adverse effect, may limit optimal management with ACE-inhibitors. We synthesized known predictors of hyperkalemia into a prognostic risk score to predict the risk of hyperkalemia. We assembled a retrospective cohort of adult patients with possible CKD (at least one estimated glomerular filtration rate (eGFR) value less than 60 ml/min/1.73 m(2)) who started an ACE-inhibitor (i.e., incident users) between 1998 and 2006 at a health maintenance organization. We followed patients for hyperkalemia: (1) potassium value >5.5 mmol/L; or (2) diagnosis code for hyperkalemia. Cox regression synthesized a priori predictors recorded in the electronic medical record into a risk score. We followed 5171 patients and 145 experienced hyperkalemia, a 90-day risk of 2.8%. Predictors included: age, eGFR, diabetes, heart failure, potassium supplements, potassium-sparing diuretics, and a high dose for the ACE-inhibitor (lisinopril). The risk score separated high-risk patients (top quintile, observ...Continue Reading

References

Jan 15, 1992·Biochemical and Biophysical Research Communications·A E HuotM P Hacker
Mar 1, 2000·Statistics in Medicine·D G Altman, P Royston
Jul 16, 2003·Annals of Internal Medicine·Andrew S LeveyUNKNOWN National Kidney Foundation
May 4, 2004·Statistics in Medicine·Lisa M SullivanRalph B D'Agostino
Jun 24, 2004·Journal of General Internal Medicine·Takeshi MorimotoDavid W Bates
Aug 6, 2004·The New England Journal of Medicine·Biff F Palmer
Jan 13, 2006·The New England Journal of Medicine·Lee A Hebert
Nov 6, 2007·American Journal of Epidemiology·Margaret S PepeYingye Zheng
Nov 7, 2007·Annals of Internal Medicine·Patrick S Parfrey
Oct 1, 2008·BMJ : British Medical Journal·Emily CroweUNKNOWN Guideline Development Group
Feb 25, 2009·BMJ : British Medical Journal·Karel G M MoonsDouglas G Altman
Apr 2, 2009·BMJ : British Medical Journal·Patrick RoystonYvonne Vergouwe
Apr 8, 2009·Journal of Clinical Epidemiology·Kevin E ThorpeKalipso Chalkidou
May 30, 2009·BMJ : British Medical Journal·Douglas G AltmanKarel G M Moons
Jun 9, 2009·BMJ : British Medical Journal·Karel G M MoonsPatrick Royston
Jun 24, 2009·Archives of Internal Medicine·Lisa M EinhornJeffrey C Fink
Sep 30, 2009·Archives of Internal Medicine·Joy M WeinbergUNKNOWN African American Study of Hypertension and Kidney Disease Collaborative Research Group

❮ Previous
Next ❯

Citations

Jun 15, 2011·Current Opinion in Nephrology and Hypertension·Zachary A Marcum, Linda F Fried
Jul 12, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Suresh Samson
Oct 24, 2013·European Journal of Clinical Pharmacology·Emmanuel EschmannJürg Blaser
Mar 23, 2011·European Journal of Clinical Pharmacology·Esther V UijtendaalToine C G Egberts
Jul 15, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·David K Packham, Mikhail Kosiborod
Jul 16, 2013·Clinics in Geriatric Medicine·Thin Thin Maw, Linda Fried
Mar 26, 2011·Pharmacoepidemiology and Drug Safety·Pernelle NoizeJean-Louis Montastruc
Feb 24, 2015·Advances in Chronic Kidney Disease·Raymond R Townsend
May 18, 2016·Journal of the American Medical Informatics Association : JAMIA·Benjamin A GoldsteinJohn P A Ioannidis
Jul 10, 2016·Pharmacotherapy·Kristin E LinderDayne Laskey
Jul 21, 2017·Journal of the American Heart Association·Ghassan BandakMorgan E Grams
Dec 18, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·James B WetmoreDavid T Gilbertson
Nov 19, 2020·ClinicoEconomics and Outcomes Research : CEOR·Ajay SharmaDingwei Dai
Jun 12, 2021·Journal of Nephrology·Antonio SantoroLuca Degli Esposti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Yang-Pei Chang, Pang-Ying Shih
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jesse D BracamontePaul Sarmiento
© 2021 Meta ULC. All rights reserved